Skip to content
Catalyst

Vaccinium macrocarponFinding

Vaccinium macrocarpon has no detected effect on HDL cholesterol

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“However, no significant decrease or increase was observed between cranberry supplementation and other blood lipid profiles: TC (MD = −0.11; 95% CI: −0.26, 0.03; peffect = 0.12), HDL-C (MD = −0.02; 95% CI: −0.05, 0.01; peffect = 0.25), LDL-C (MD = −0.10; 95% CI: −0.20, 0.01; peffect = 0.07), and TG (MD = 0.06; 95% CI: 0.00, 0.12; peffect = 0.05).”
Quoted verbatim from The Effects of Cranberry Consumption on Glycemic and Lipid Profiles in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
This finding among the 93 findings on its endpoint

Vaccinium macrocarpon

HDL cholesterol

no difference found

Effect as reported

−0.02mean difference

CI −0.05 to 0.01

Who
Adults aged 18 to 80 in randomized placebo-controlled trials of cranberry supplementation (healthy people and patients with overweight or obesity, diabetes, cardiovascular disease, metabolic syndrome or non-alcoholic fatty liver); pooled estimate
Dose studied
Pooled doses: capsules or tablets 144 to 1500 mg/day, powder 9 g/day, juice 240 to 750 mL/day; intervention length 2 weeks to 6 months

Moderate evidencePMID 38542695 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Nutrients
What else it reported7 findings · 0 compounds · 7 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y1CMH5XYZGZ0MVE3R5XA07